Try our beta test site
2299 studies found for:    ADULT SYNDROME
Show Display Options
Rank Status Study
21 Active, not recruiting Natural History of Amyloid Deposition in Adults With Down Syndrome
Condition: Down Syndrome
Intervention:
22 Terminated Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)
Condition: Respiratory Distress Syndrome, Adult
Interventions: Behavioral: Minimal (Trophic) Feeding;   Behavioral: Full Feeding;   Dietary Supplement: Omega-3 Fatty Acids and Antioxidant Supplements;   Dietary Supplement: Placebo
23 Terminated Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome
Condition: Tourette's Syndrome
Interventions: Drug: PF-03654746;   Drug: Placebo
24 Completed Open-Trial of EPI-743 for Adults With Tourette Syndrome
Condition: Tourette Syndrome
Intervention: Drug: EPI-743
25 Active, not recruiting Assessing the Feasibility of the Use of Visual Aids in Patient Education in Adults With Down Syndrome (DS)
Condition: Down Syndrome
Interventions: Behavioral: Verbal instructions with picture diagram;   Behavioral: Verbal instructions with video of ADSC;   Behavioral: verbal instructions w. video of w/o DS;   Behavioral: verbal instructions w. video w/DS
26 Completed Adaptation Among Adolescents and Adults With Klinefelter Syndrome
Condition: Klinefelter Syndrome
Intervention:
27 Suspended FAAH Inhibitor Trial for Adults With Tourette Syndrome
Condition: Tourette Syndrome
Interventions: Drug: PF-04457845;   Drug: Placebo
28 Withdrawn Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial
Condition: Metabolic Syndrome
Intervention: Behavioral: Promotora plus standard physical screening exam , hemoglobin A1c levels, lipid panels, fasting glucose, height, weight, BMI, Complete Blood Count
29 Completed Evaluation of a Simplified Method for Diagnosis of Sleep Apnea in Children and Adults With Down Syndrome
Condition: Down Syndrome
Intervention: Other: Polysomnography
30 Completed Changes in Refractory Acute Respiratory Distress Syndrome (ARDS) Patients Under High Frequency Oscillation-ventilation
Condition: Respiratory Distress Syndrome, Adult
Intervention:
31 Completed Methionine-Restriction Diet (MRD) in Obese Adults With Metabolic Syndrome
Condition: Metabolic Syndrome
Interventions: Dietary Supplement: Methionine deficient diet;   Dietary Supplement: Methionine sufficient diet
32 Completed Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.
Condition: Irritable Bowel Syndrome
Intervention:
33 Recruiting A Study in Adults With Angelman Syndrome
Condition: Angelman Syndrome
Interventions: Drug: OV101 Regimen 1;   Drug: OV101 regimen 2;   Other: Placebo
34 Completed Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome
Condition: Fragile X Syndrome
Interventions: Drug: AFQ056;   Drug: Placebo
35 Completed A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome
Condition: Fragile X Syndrome
Intervention: Drug: MG01CI extended-release tablet
36 Completed A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)
Condition: Down Syndrome
Interventions: Drug: Placebo;   Drug: RG1662
37 Completed Hemodynamic Assessment With Trans-esophageal Doppler (TED) During Prone Ventilation in ARDS Patients
Condition: Respiratory Distress Syndrome, Adult
Intervention:
38 Unknown  Growth Hormone Use in Adults With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Nutropin AQ
39 Completed Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome
Condition: Prader-Willi Syndrome
Intervention: Drug: Norditropin SimpleXx
40 Recruiting Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.
Conditions: Adult Patients With Low Risk Myelodysplastic Syndrome;   Adult Patients With Int 1-risk Myelodysplastic Syndrome
Interventions: Drug: Erythropoietin alpha;   Drug: Deferasirox

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.